nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—NTRK1—Amitriptyline—migraine	0.321	0.653	CbGbCtD
Crizotinib—CYP3A5—Propranolol—migraine	0.0233	0.0474	CbGbCtD
Crizotinib—CYP3A5—Amitriptyline—migraine	0.0202	0.041	CbGbCtD
Crizotinib—CYP3A5—Valproic Acid—migraine	0.0184	0.0374	CbGbCtD
Crizotinib—ABCB1—Timolol—migraine	0.017	0.0346	CbGbCtD
Crizotinib—CYP3A5—Verapamil—migraine	0.016	0.0326	CbGbCtD
Crizotinib—ABCB1—Propranolol—migraine	0.0152	0.0309	CbGbCtD
Crizotinib—ABCB1—Amitriptyline—migraine	0.0131	0.0267	CbGbCtD
Crizotinib—ABCB1—Verapamil—migraine	0.0104	0.0212	CbGbCtD
Crizotinib—CYP3A4—Propranolol—migraine	0.00909	0.0185	CbGbCtD
Crizotinib—CYP3A4—Amitriptyline—migraine	0.00786	0.016	CbGbCtD
Crizotinib—CYP3A4—Valproic Acid—migraine	0.00716	0.0146	CbGbCtD
Crizotinib—CYP3A4—Topiramate—migraine	0.00646	0.0132	CbGbCtD
Crizotinib—CYP3A4—Verapamil—migraine	0.00624	0.0127	CbGbCtD
Crizotinib—PTK2B—Pindolol—Propranolol—migraine	0.00162	0.51	CbGdCrCtD
Crizotinib—CDK7—Terbinafine—Propranolol—migraine	0.00156	0.49	CbGdCrCtD
Crizotinib—Visual impairment—Propranolol—migraine	0.000771	0.00433	CcSEcCtD
Crizotinib—Syncope—Amitriptyline—migraine	0.000767	0.00431	CcSEcCtD
Crizotinib—Leukopenia—Amitriptyline—migraine	0.000766	0.0043	CcSEcCtD
Crizotinib—Diplopia—Valproic Acid—migraine	0.000754	0.00424	CcSEcCtD
Crizotinib—Loss of consciousness—Amitriptyline—migraine	0.000752	0.00423	CcSEcCtD
Crizotinib—Bradycardia—Verapamil—migraine	0.000749	0.00421	CcSEcCtD
Crizotinib—Sepsis—Gabapentin—migraine	0.000748	0.0042	CcSEcCtD
Crizotinib—Gait disturbance—Topiramate—migraine	0.000743	0.00417	CcSEcCtD
Crizotinib—Cardiac disorder—Propranolol—migraine	0.000743	0.00417	CcSEcCtD
Crizotinib—Hypoaesthesia—Verapamil—migraine	0.000732	0.00412	CcSEcCtD
Crizotinib—Face oedema—Valproic Acid—migraine	0.000728	0.00409	CcSEcCtD
Crizotinib—Oedema peripheral—Verapamil—migraine	0.000725	0.00408	CcSEcCtD
Crizotinib—Phosphatase alkaline increased—Topiramate—migraine	0.000725	0.00407	CcSEcCtD
Crizotinib—Pulmonary embolism—Topiramate—migraine	0.000725	0.00407	CcSEcCtD
Crizotinib—Blood alkaline phosphatase increased—Gabapentin—migraine	0.000719	0.00404	CcSEcCtD
Crizotinib—Hepatic function abnormal—Gabapentin—migraine	0.000716	0.00402	CcSEcCtD
Crizotinib—Visual impairment—Verapamil—migraine	0.000709	0.00399	CcSEcCtD
Crizotinib—Visual disturbance—Timolol—migraine	0.000709	0.00398	CcSEcCtD
Crizotinib—Oedema—Amitriptyline—migraine	0.000698	0.00392	CcSEcCtD
Crizotinib—Hepatic failure—Gabapentin—migraine	0.000696	0.00391	CcSEcCtD
Crizotinib—Fluid retention—Topiramate—migraine	0.000688	0.00387	CcSEcCtD
Crizotinib—Shock—Amitriptyline—migraine	0.000687	0.00386	CcSEcCtD
Crizotinib—Neuropathy—Topiramate—migraine	0.00068	0.00383	CcSEcCtD
Crizotinib—Photophobia—Topiramate—migraine	0.00068	0.00383	CcSEcCtD
Crizotinib—Aspartate aminotransferase increased—Valproic Acid—migraine	0.000679	0.00382	CcSEcCtD
Crizotinib—Diplopia—Timolol—migraine	0.000672	0.00378	CcSEcCtD
Crizotinib—Muscular weakness—Valproic Acid—migraine	0.000665	0.00374	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Valproic Acid—migraine	0.000665	0.00374	CcSEcCtD
Crizotinib—Paraesthesia—Amitriptyline—migraine	0.000627	0.00352	CcSEcCtD
Crizotinib—Diplopia—Gabapentin—migraine	0.000625	0.00352	CcSEcCtD
Crizotinib—Dyspepsia—Amitriptyline—migraine	0.000615	0.00345	CcSEcCtD
Crizotinib—Neutropenia—Valproic Acid—migraine	0.00061	0.00343	CcSEcCtD
Crizotinib—Decreased appetite—Amitriptyline—migraine	0.000607	0.00341	CcSEcCtD
Crizotinib—Blood alkaline phosphatase increased—Topiramate—migraine	0.000605	0.0034	CcSEcCtD
Crizotinib—Vision blurred—Verapamil—migraine	0.000604	0.00339	CcSEcCtD
Crizotinib—Face oedema—Gabapentin—migraine	0.000604	0.00339	CcSEcCtD
Crizotinib—Fatigue—Amitriptyline—migraine	0.000602	0.00338	CcSEcCtD
Crizotinib—Constipation—Amitriptyline—migraine	0.000597	0.00336	CcSEcCtD
Crizotinib—Weight decreased—Valproic Acid—migraine	0.00059	0.00332	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000589	0.00331	CcSEcCtD
Crizotinib—Hepatic failure—Topiramate—migraine	0.000585	0.00329	CcSEcCtD
Crizotinib—Pneumonia—Valproic Acid—migraine	0.000585	0.00329	CcSEcCtD
Crizotinib—Syncope—Verapamil—migraine	0.000575	0.00323	CcSEcCtD
Crizotinib—Infection—Propranolol—migraine	0.000565	0.00317	CcSEcCtD
Crizotinib—Loss of consciousness—Verapamil—migraine	0.000563	0.00317	CcSEcCtD
Crizotinib—Nervous system disorder—Propranolol—migraine	0.000557	0.00313	CcSEcCtD
Crizotinib—Visual disturbance—Topiramate—migraine	0.000555	0.00312	CcSEcCtD
Crizotinib—Skin disorder—Propranolol—migraine	0.000552	0.0031	CcSEcCtD
Crizotinib—Body temperature increased—Amitriptyline—migraine	0.000552	0.0031	CcSEcCtD
Crizotinib—Muscular weakness—Gabapentin—migraine	0.000552	0.0031	CcSEcCtD
Crizotinib—Hepatobiliary disease—Valproic Acid—migraine	0.00055	0.00309	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Timolol—migraine	0.000539	0.00303	CcSEcCtD
Crizotinib—Bradycardia—Valproic Acid—migraine	0.000531	0.00299	CcSEcCtD
Crizotinib—Diplopia—Topiramate—migraine	0.000526	0.00296	CcSEcCtD
Crizotinib—Weight decreased—Timolol—migraine	0.000525	0.00295	CcSEcCtD
Crizotinib—Oedema—Verapamil—migraine	0.000523	0.00294	CcSEcCtD
Crizotinib—Infection—Verapamil—migraine	0.000519	0.00292	CcSEcCtD
Crizotinib—Hypoaesthesia—Valproic Acid—migraine	0.000519	0.00292	CcSEcCtD
Crizotinib—Urinary tract disorder—Valproic Acid—migraine	0.000515	0.0029	CcSEcCtD
Crizotinib—Shock—Verapamil—migraine	0.000514	0.00289	CcSEcCtD
Crizotinib—Oedema peripheral—Valproic Acid—migraine	0.000514	0.00289	CcSEcCtD
Crizotinib—Urethral disorder—Valproic Acid—migraine	0.000512	0.00288	CcSEcCtD
Crizotinib—Paraesthesia—Propranolol—migraine	0.00051	0.00287	CcSEcCtD
Crizotinib—Face oedema—Topiramate—migraine	0.000508	0.00286	CcSEcCtD
Crizotinib—Dyspnoea—Propranolol—migraine	0.000507	0.00285	CcSEcCtD
Crizotinib—Visual impairment—Valproic Acid—migraine	0.000503	0.00283	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Gabapentin—migraine	0.000502	0.00282	CcSEcCtD
Crizotinib—Asthenia—Amitriptyline—migraine	0.000501	0.00282	CcSEcCtD
Crizotinib—Dyspepsia—Propranolol—migraine	0.0005	0.00281	CcSEcCtD
Crizotinib—Decreased appetite—Propranolol—migraine	0.000494	0.00278	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Propranolol—migraine	0.000491	0.00276	CcSEcCtD
Crizotinib—Fatigue—Propranolol—migraine	0.00049	0.00276	CcSEcCtD
Crizotinib—Weight decreased—Gabapentin—migraine	0.000489	0.00275	CcSEcCtD
Crizotinib—Eye disorder—Valproic Acid—migraine	0.000488	0.00274	CcSEcCtD
Crizotinib—Constipation—Propranolol—migraine	0.000486	0.00273	CcSEcCtD
Crizotinib—Pneumonia—Gabapentin—migraine	0.000485	0.00272	CcSEcCtD
Crizotinib—Infestation NOS—Gabapentin—migraine	0.000482	0.00271	CcSEcCtD
Crizotinib—Infestation—Gabapentin—migraine	0.000482	0.00271	CcSEcCtD
Crizotinib—Hypokalaemia—Topiramate—migraine	0.000479	0.00269	CcSEcCtD
Crizotinib—Diarrhoea—Amitriptyline—migraine	0.000478	0.00269	CcSEcCtD
Crizotinib—Aspartate aminotransferase increased—Topiramate—migraine	0.000474	0.00266	CcSEcCtD
Crizotinib—Bradycardia—Timolol—migraine	0.000473	0.00266	CcSEcCtD
Crizotinib—Neuropathy peripheral—Gabapentin—migraine	0.000472	0.00266	CcSEcCtD
Crizotinib—Mediastinal disorder—Valproic Acid—migraine	0.00047	0.00264	CcSEcCtD
Crizotinib—Paraesthesia—Verapamil—migraine	0.00047	0.00264	CcSEcCtD
Crizotinib—Arrhythmia—Valproic Acid—migraine	0.000466	0.00262	CcSEcCtD
Crizotinib—Dyspnoea—Verapamil—migraine	0.000466	0.00262	CcSEcCtD
Crizotinib—Muscular weakness—Topiramate—migraine	0.000464	0.00261	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Topiramate—migraine	0.000464	0.00261	CcSEcCtD
Crizotinib—Dizziness—Amitriptyline—migraine	0.000462	0.0026	CcSEcCtD
Crizotinib—Dyspepsia—Verapamil—migraine	0.00046	0.00259	CcSEcCtD
Crizotinib—Oedema peripheral—Timolol—migraine	0.000458	0.00257	CcSEcCtD
Crizotinib—Hepatobiliary disease—Gabapentin—migraine	0.000456	0.00256	CcSEcCtD
Crizotinib—Malnutrition—Valproic Acid—migraine	0.000454	0.00255	CcSEcCtD
Crizotinib—Fatigue—Verapamil—migraine	0.000451	0.00253	CcSEcCtD
Crizotinib—Body temperature increased—Propranolol—migraine	0.000449	0.00253	CcSEcCtD
Crizotinib—Visual impairment—Timolol—migraine	0.000448	0.00252	CcSEcCtD
Crizotinib—Constipation—Verapamil—migraine	0.000447	0.00251	CcSEcCtD
Crizotinib—Dysgeusia—Valproic Acid—migraine	0.000445	0.0025	CcSEcCtD
Crizotinib—Vomiting—Amitriptyline—migraine	0.000444	0.0025	CcSEcCtD
Crizotinib—Bradycardia—Gabapentin—migraine	0.00044	0.00248	CcSEcCtD
Crizotinib—Rash—Amitriptyline—migraine	0.00044	0.00247	CcSEcCtD
Crizotinib—Dermatitis—Amitriptyline—migraine	0.00044	0.00247	CcSEcCtD
Crizotinib—Eye disorder—Timolol—migraine	0.000434	0.00244	CcSEcCtD
Crizotinib—JAK3—central nervous system—migraine	0.000433	0.00258	CbGeAlD
Crizotinib—EPHA6—central nervous system—migraine	0.000433	0.00258	CbGeAlD
Crizotinib—MAP3K19—head—migraine	0.000431	0.00257	CbGeAlD
Crizotinib—BMPR1B—head—migraine	0.000431	0.00257	CbGeAlD
Crizotinib—Cardiac disorder—Timolol—migraine	0.000431	0.00242	CcSEcCtD
Crizotinib—DCLK1—central nervous system—migraine	0.00043	0.00256	CbGeAlD
Crizotinib—Hypoaesthesia—Gabapentin—migraine	0.00043	0.00242	CcSEcCtD
Crizotinib—LTK—brain—migraine	0.00043	0.00256	CbGeAlD
Crizotinib—CASK—brain—migraine	0.00043	0.00256	CbGeAlD
Crizotinib—Vision blurred—Valproic Acid—migraine	0.000428	0.00241	CcSEcCtD
Crizotinib—Urinary tract disorder—Gabapentin—migraine	0.000427	0.0024	CcSEcCtD
Crizotinib—Oedema peripheral—Gabapentin—migraine	0.000426	0.0024	CcSEcCtD
Crizotinib—STK4—central nervous system—migraine	0.000425	0.00253	CbGeAlD
Crizotinib—Neutropenia—Topiramate—migraine	0.000425	0.00239	CcSEcCtD
Crizotinib—Urethral disorder—Gabapentin—migraine	0.000424	0.00238	CcSEcCtD
Crizotinib—JAK3—cerebellum—migraine	0.000423	0.00252	CbGeAlD
Crizotinib—TNK2—head—migraine	0.000423	0.00252	CbGeAlD
Crizotinib—IGF1R—head—migraine	0.000423	0.00252	CbGeAlD
Crizotinib—Upper respiratory tract infection—Topiramate—migraine	0.000423	0.00238	CcSEcCtD
Crizotinib—EPHB4—cardiovascular system—migraine	0.000422	0.00251	CbGeAlD
Crizotinib—DCLK1—cerebellum—migraine	0.000421	0.0025	CbGeAlD
Crizotinib—Anaemia—Valproic Acid—migraine	0.00042	0.00236	CcSEcCtD
Crizotinib—JAK2—cardiovascular system—migraine	0.000419	0.00249	CbGeAlD
Crizotinib—Mediastinal disorder—Timolol—migraine	0.000419	0.00235	CcSEcCtD
Crizotinib—FER—nervous system—migraine	0.000417	0.00248	CbGeAlD
Crizotinib—TYRO3—nervous system—migraine	0.000417	0.00248	CbGeAlD
Crizotinib—EPHA5—nervous system—migraine	0.000417	0.00248	CbGeAlD
Crizotinib—ALK—nervous system—migraine	0.000417	0.00248	CbGeAlD
Crizotinib—Visual impairment—Gabapentin—migraine	0.000417	0.00234	CcSEcCtD
Crizotinib—MAPK7—brain—migraine	0.000417	0.00248	CbGeAlD
Crizotinib—STK4—cerebellum—migraine	0.000416	0.00247	CbGeAlD
Crizotinib—LYN—nervous system—migraine	0.000415	0.00247	CbGeAlD
Crizotinib—Arrhythmia—Timolol—migraine	0.000415	0.00233	CcSEcCtD
Crizotinib—Nausea—Amitriptyline—migraine	0.000415	0.00233	CcSEcCtD
Crizotinib—EPHA2—cardiovascular system—migraine	0.000414	0.00246	CbGeAlD
Crizotinib—EPHA8—brain—migraine	0.000412	0.00246	CbGeAlD
Crizotinib—FES—brain—migraine	0.000412	0.00246	CbGeAlD
Crizotinib—TIE1—head—migraine	0.000411	0.00245	CbGeAlD
Crizotinib—STK3—head—migraine	0.000411	0.00245	CbGeAlD
Crizotinib—Weight decreased—Topiramate—migraine	0.000411	0.00231	CcSEcCtD
Crizotinib—BMPR1B—nervous system—migraine	0.000409	0.00243	CbGeAlD
Crizotinib—MAP3K19—nervous system—migraine	0.000409	0.00243	CbGeAlD
Crizotinib—Asthenia—Propranolol—migraine	0.000408	0.00229	CcSEcCtD
Crizotinib—Pneumonia—Topiramate—migraine	0.000408	0.00229	CcSEcCtD
Crizotinib—Leukopenia—Valproic Acid—migraine	0.000407	0.00229	CcSEcCtD
Crizotinib—Infestation—Topiramate—migraine	0.000405	0.00228	CcSEcCtD
Crizotinib—Infestation NOS—Topiramate—migraine	0.000405	0.00228	CcSEcCtD
Crizotinib—Malnutrition—Timolol—migraine	0.000404	0.00227	CcSEcCtD
Crizotinib—Eye disorder—Gabapentin—migraine	0.000404	0.00227	CcSEcCtD
Crizotinib—MAP3K3—cardiovascular system—migraine	0.000404	0.0024	CbGeAlD
Crizotinib—TEK—cardiovascular system—migraine	0.000404	0.0024	CbGeAlD
Crizotinib—ALK—central nervous system—migraine	0.000402	0.00239	CbGeAlD
Crizotinib—TYRO3—central nervous system—migraine	0.000402	0.00239	CbGeAlD
Crizotinib—FER—central nervous system—migraine	0.000402	0.00239	CbGeAlD
Crizotinib—EPHA5—central nervous system—migraine	0.000402	0.00239	CbGeAlD
Crizotinib—Cardiac disorder—Gabapentin—migraine	0.000401	0.00226	CcSEcCtD
Crizotinib—TNK2—nervous system—migraine	0.000401	0.00239	CbGeAlD
Crizotinib—IGF1R—nervous system—migraine	0.000401	0.00239	CbGeAlD
Crizotinib—AURKA—head—migraine	0.000401	0.00239	CbGeAlD
Crizotinib—LYN—central nervous system—migraine	0.0004	0.00238	CbGeAlD
Crizotinib—TESK1—head—migraine	0.000398	0.00237	CbGeAlD
Crizotinib—Neuropathy peripheral—Topiramate—migraine	0.000397	0.00223	CcSEcCtD
Crizotinib—Dysgeusia—Timolol—migraine	0.000396	0.00223	CcSEcCtD
Crizotinib—MAP3K19—central nervous system—migraine	0.000394	0.00234	CbGeAlD
Crizotinib—BMPR1B—central nervous system—migraine	0.000394	0.00234	CbGeAlD
Crizotinib—EPHA5—cerebellum—migraine	0.000393	0.00234	CbGeAlD
Crizotinib—TYRO3—cerebellum—migraine	0.000393	0.00234	CbGeAlD
Crizotinib—FER—cerebellum—migraine	0.000393	0.00234	CbGeAlD
Crizotinib—TIE1—nervous system—migraine	0.00039	0.00232	CbGeAlD
Crizotinib—MET—brain—migraine	0.00039	0.00232	CbGeAlD
Crizotinib—Mediastinal disorder—Gabapentin—migraine	0.00039	0.00219	CcSEcCtD
Crizotinib—Diarrhoea—Propranolol—migraine	0.000389	0.00219	CcSEcCtD
Crizotinib—TNK1—cerebellum—migraine	0.000389	0.00231	CbGeAlD
Crizotinib—MERTK—head—migraine	0.000387	0.0023	CbGeAlD
Crizotinib—TNK2—central nervous system—migraine	0.000386	0.0023	CbGeAlD
Crizotinib—IGF1R—central nervous system—migraine	0.000386	0.0023	CbGeAlD
Crizotinib—BMPR1B—cerebellum—migraine	0.000385	0.00229	CbGeAlD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000384	0.00216	CcSEcCtD
Crizotinib—Vision blurred—Timolol—migraine	0.000381	0.00214	CcSEcCtD
Crizotinib—AURKA—nervous system—migraine	0.00038	0.00226	CbGeAlD
Crizotinib—LIMK2—head—migraine	0.000378	0.00225	CbGeAlD
Crizotinib—TNK2—cerebellum—migraine	0.000377	0.00225	CbGeAlD
Crizotinib—IGF1R—cerebellum—migraine	0.000377	0.00225	CbGeAlD
Crizotinib—CDK7—brain—migraine	0.000377	0.00225	CbGeAlD
Crizotinib—TESK1—nervous system—migraine	0.000377	0.00224	CbGeAlD
Crizotinib—Malnutrition—Gabapentin—migraine	0.000377	0.00212	CcSEcCtD
Crizotinib—Dizziness—Propranolol—migraine	0.000376	0.00211	CcSEcCtD
Crizotinib—TIE1—central nervous system—migraine	0.000376	0.00224	CbGeAlD
Crizotinib—Asthenia—Verapamil—migraine	0.000375	0.00211	CcSEcCtD
Crizotinib—MAP3K12—head—migraine	0.000374	0.00223	CbGeAlD
Crizotinib—ACVR1—head—migraine	0.000374	0.00223	CbGeAlD
Crizotinib—TAOK2—brain—migraine	0.000374	0.00223	CbGeAlD
Crizotinib—MAP4K2—cerebellum—migraine	0.000372	0.00222	CbGeAlD
Crizotinib—Oedema—Valproic Acid—migraine	0.000371	0.00208	CcSEcCtD
Crizotinib—Bradycardia—Topiramate—migraine	0.000371	0.00208	CcSEcCtD
Crizotinib—STK10—cardiovascular system—migraine	0.00037	0.0022	CbGeAlD
Crizotinib—Dysgeusia—Gabapentin—migraine	0.000369	0.00207	CcSEcCtD
Crizotinib—Infection—Valproic Acid—migraine	0.000368	0.00207	CcSEcCtD
Crizotinib—TAOK3—cardiovascular system—migraine	0.000368	0.00219	CbGeAlD
Crizotinib—TIE1—cerebellum—migraine	0.000367	0.00219	CbGeAlD
Crizotinib—STK3—cerebellum—migraine	0.000367	0.00219	CbGeAlD
Crizotinib—MERTK—nervous system—migraine	0.000367	0.00218	CbGeAlD
Crizotinib—STK35—head—migraine	0.000367	0.00218	CbGeAlD
Crizotinib—AURKA—central nervous system—migraine	0.000366	0.00218	CbGeAlD
Crizotinib—Nervous system disorder—Valproic Acid—migraine	0.000364	0.00204	CcSEcCtD
Crizotinib—TESK1—central nervous system—migraine	0.000363	0.00216	CbGeAlD
Crizotinib—Syncope—Timolol—migraine	0.000363	0.00204	CcSEcCtD
Crizotinib—Hypoaesthesia—Topiramate—migraine	0.000362	0.00204	CcSEcCtD
Crizotinib—Vomiting—Propranolol—migraine	0.000361	0.00203	CcSEcCtD
Crizotinib—ACVR1B—brain—migraine	0.000361	0.00215	CbGeAlD
Crizotinib—EPHA3—brain—migraine	0.000361	0.00215	CbGeAlD
Crizotinib—Skin disorder—Valproic Acid—migraine	0.00036	0.00202	CcSEcCtD
Crizotinib—Urinary tract disorder—Topiramate—migraine	0.000359	0.00202	CcSEcCtD
Crizotinib—SRC—cardiovascular system—migraine	0.000359	0.00214	CbGeAlD
Crizotinib—LIMK2—nervous system—migraine	0.000359	0.00214	CbGeAlD
Crizotinib—Oedema peripheral—Topiramate—migraine	0.000359	0.00202	CcSEcCtD
Crizotinib—Rash—Propranolol—migraine	0.000358	0.00201	CcSEcCtD
Crizotinib—Dermatitis—Propranolol—migraine	0.000358	0.00201	CcSEcCtD
Crizotinib—Diarrhoea—Verapamil—migraine	0.000358	0.00201	CcSEcCtD
Crizotinib—Urethral disorder—Topiramate—migraine	0.000357	0.00201	CcSEcCtD
Crizotinib—Loss of consciousness—Timolol—migraine	0.000355	0.002	CcSEcCtD
Crizotinib—MAP3K12—nervous system—migraine	0.000355	0.00211	CbGeAlD
Crizotinib—ACVR1—nervous system—migraine	0.000355	0.00211	CbGeAlD
Crizotinib—Vision blurred—Gabapentin—migraine	0.000355	0.002	CcSEcCtD
Crizotinib—TESK1—cerebellum—migraine	0.000355	0.00211	CbGeAlD
Crizotinib—MERTK—central nervous system—migraine	0.000353	0.0021	CbGeAlD
Crizotinib—BMP2K—head—migraine	0.000353	0.0021	CbGeAlD
Crizotinib—ABL1—trigeminal ganglion—migraine	0.000353	0.0021	CbGeAlD
Crizotinib—Visual impairment—Topiramate—migraine	0.000351	0.00197	CcSEcCtD
Crizotinib—Anaemia—Gabapentin—migraine	0.000348	0.00196	CcSEcCtD
Crizotinib—STK35—nervous system—migraine	0.000348	0.00207	CbGeAlD
Crizotinib—Dizziness—Verapamil—migraine	0.000346	0.00194	CcSEcCtD
Crizotinib—LIMK2—central nervous system—migraine	0.000345	0.00206	CbGeAlD
Crizotinib—MERTK—cerebellum—migraine	0.000345	0.00205	CbGeAlD
Crizotinib—EPHA6—brain—migraine	0.000344	0.00205	CbGeAlD
Crizotinib—JAK3—brain—migraine	0.000344	0.00205	CbGeAlD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000342	0.00192	CcSEcCtD
Crizotinib—DCLK1—brain—migraine	0.000342	0.00203	CbGeAlD
Crizotinib—MAP3K12—central nervous system—migraine	0.000342	0.00203	CbGeAlD
Crizotinib—ACVR1—central nervous system—migraine	0.000342	0.00203	CbGeAlD
Crizotinib—PTK2B—head—migraine	0.000341	0.00203	CbGeAlD
Crizotinib—Eye disorder—Topiramate—migraine	0.00034	0.00191	CcSEcCtD
Crizotinib—PLK4—brain—migraine	0.00034	0.00202	CbGeAlD
Crizotinib—RIPK2—head—migraine	0.000338	0.00201	CbGeAlD
Crizotinib—Cardiac disorder—Topiramate—migraine	0.000338	0.0019	CcSEcCtD
Crizotinib—Syncope—Gabapentin—migraine	0.000338	0.0019	CcSEcCtD
Crizotinib—Nausea—Propranolol—migraine	0.000338	0.0019	CcSEcCtD
Crizotinib—STK4—brain—migraine	0.000338	0.00201	CbGeAlD
Crizotinib—LIMK2—cerebellum—migraine	0.000338	0.00201	CbGeAlD
Crizotinib—Leukopenia—Gabapentin—migraine	0.000337	0.0019	CcSEcCtD
Crizotinib—NUAK2—cerebellum—migraine	0.000336	0.002	CbGeAlD
Crizotinib—STK35—central nervous system—migraine	0.000335	0.00199	CbGeAlD
Crizotinib—BMP2K—nervous system—migraine	0.000335	0.00199	CbGeAlD
Crizotinib—MAP3K12—cerebellum—migraine	0.000334	0.00199	CbGeAlD
Crizotinib—FLT3—cerebellum—migraine	0.000334	0.00199	CbGeAlD
Crizotinib—ACVR1—cerebellum—migraine	0.000334	0.00199	CbGeAlD
Crizotinib—Paraesthesia—Valproic Acid—migraine	0.000333	0.00187	CcSEcCtD
Crizotinib—Vomiting—Verapamil—migraine	0.000332	0.00187	CcSEcCtD
Crizotinib—Loss of consciousness—Gabapentin—migraine	0.000331	0.00186	CcSEcCtD
Crizotinib—Dyspnoea—Valproic Acid—migraine	0.000331	0.00186	CcSEcCtD
Crizotinib—Oedema—Timolol—migraine	0.00033	0.00186	CcSEcCtD
Crizotinib—Rash—Verapamil—migraine	0.00033	0.00185	CcSEcCtD
Crizotinib—Dermatitis—Verapamil—migraine	0.000329	0.00185	CcSEcCtD
Crizotinib—Mediastinal disorder—Topiramate—migraine	0.000328	0.00184	CcSEcCtD
Crizotinib—Infection—Timolol—migraine	0.000328	0.00184	CcSEcCtD
Crizotinib—STK35—cerebellum—migraine	0.000327	0.00195	CbGeAlD
Crizotinib—EPHA4—head—migraine	0.000327	0.00195	CbGeAlD
Crizotinib—Dyspepsia—Valproic Acid—migraine	0.000326	0.00183	CcSEcCtD
Crizotinib—Shock—Timolol—migraine	0.000325	0.00183	CcSEcCtD
Crizotinib—Nervous system disorder—Timolol—migraine	0.000324	0.00182	CcSEcCtD
Crizotinib—PTK2B—nervous system—migraine	0.000323	0.00192	CbGeAlD
Crizotinib—Decreased appetite—Valproic Acid—migraine	0.000322	0.00181	CcSEcCtD
Crizotinib—BMP2K—central nervous system—migraine	0.000322	0.00192	CbGeAlD
Crizotinib—CSF1R—cardiovascular system—migraine	0.000322	0.00192	CbGeAlD
Crizotinib—Skin disorder—Timolol—migraine	0.000321	0.0018	CcSEcCtD
Crizotinib—MAP3K2—head—migraine	0.000321	0.00191	CbGeAlD
Crizotinib—Gastrointestinal disorder—Valproic Acid—migraine	0.00032	0.0018	CcSEcCtD
Crizotinib—Fatigue—Valproic Acid—migraine	0.00032	0.0018	CcSEcCtD
Crizotinib—EPHA5—brain—migraine	0.000319	0.0019	CbGeAlD
Crizotinib—ALK—brain—migraine	0.000319	0.0019	CbGeAlD
Crizotinib—TYRO3—brain—migraine	0.000319	0.0019	CbGeAlD
Crizotinib—FER—brain—migraine	0.000319	0.0019	CbGeAlD
Crizotinib—ABL2—cerebellum—migraine	0.000319	0.0019	CbGeAlD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000318	0.00179	CcSEcCtD
Crizotinib—LYN—brain—migraine	0.000317	0.00189	CbGeAlD
Crizotinib—Constipation—Valproic Acid—migraine	0.000317	0.00178	CcSEcCtD
Crizotinib—Malnutrition—Topiramate—migraine	0.000317	0.00178	CcSEcCtD
Crizotinib—TNK1—brain—migraine	0.000316	0.00188	CbGeAlD
Crizotinib—BMP2K—cerebellum—migraine	0.000315	0.00187	CbGeAlD
Crizotinib—TBK1—head—migraine	0.000314	0.00187	CbGeAlD
Crizotinib—PTK2—head—migraine	0.000314	0.00187	CbGeAlD
Crizotinib—MAP3K19—brain—migraine	0.000313	0.00186	CbGeAlD
Crizotinib—MAP4K1—brain—migraine	0.000313	0.00186	CbGeAlD
Crizotinib—BMPR1B—brain—migraine	0.000313	0.00186	CbGeAlD
Crizotinib—ABL1—brainstem—migraine	0.000312	0.00186	CbGeAlD
Crizotinib—TYK2—head—migraine	0.000312	0.00186	CbGeAlD
Crizotinib—PTK2B—central nervous system—migraine	0.000311	0.00185	CbGeAlD
Crizotinib—Nausea—Verapamil—migraine	0.000311	0.00175	CcSEcCtD
Crizotinib—Dysgeusia—Topiramate—migraine	0.00031	0.00174	CcSEcCtD
Crizotinib—EPHA4—nervous system—migraine	0.00031	0.00184	CbGeAlD
Crizotinib—Oedema—Gabapentin—migraine	0.000307	0.00173	CcSEcCtD
Crizotinib—TNK2—brain—migraine	0.000307	0.00182	CbGeAlD
Crizotinib—IGF1R—brain—migraine	0.000307	0.00182	CbGeAlD
Crizotinib—Infection—Gabapentin—migraine	0.000305	0.00172	CcSEcCtD
Crizotinib—PTK2B—cerebellum—migraine	0.000304	0.00181	CbGeAlD
Crizotinib—MAP3K2—nervous system—migraine	0.000304	0.00181	CbGeAlD
Crizotinib—Shock—Gabapentin—migraine	0.000302	0.0017	CcSEcCtD
Crizotinib—MAP4K2—brain—migraine	0.000302	0.0018	CbGeAlD
Crizotinib—RPS6KB1—head—migraine	0.000302	0.0018	CbGeAlD
Crizotinib—RIPK2—cerebellum—migraine	0.000302	0.0018	CbGeAlD
Crizotinib—Nervous system disorder—Gabapentin—migraine	0.000301	0.00169	CcSEcCtD
Crizotinib—FGR—head—migraine	0.0003	0.00179	CbGeAlD
Crizotinib—AXL—head—migraine	0.000299	0.00178	CbGeAlD
Crizotinib—Vision blurred—Topiramate—migraine	0.000299	0.00168	CcSEcCtD
Crizotinib—Skin disorder—Gabapentin—migraine	0.000299	0.00168	CcSEcCtD
Crizotinib—EPHA4—central nervous system—migraine	0.000298	0.00178	CbGeAlD
Crizotinib—STK3—brain—migraine	0.000298	0.00177	CbGeAlD
Crizotinib—TIE1—brain—migraine	0.000298	0.00177	CbGeAlD
Crizotinib—TBK1—nervous system—migraine	0.000298	0.00177	CbGeAlD
Crizotinib—PTK2—nervous system—migraine	0.000298	0.00177	CbGeAlD
Crizotinib—Paraesthesia—Timolol—migraine	0.000296	0.00167	CcSEcCtD
Crizotinib—TYK2—nervous system—migraine	0.000296	0.00176	CbGeAlD
Crizotinib—Dyspnoea—Timolol—migraine	0.000294	0.00165	CcSEcCtD
Crizotinib—Body temperature increased—Valproic Acid—migraine	0.000293	0.00165	CcSEcCtD
Crizotinib—Anaemia—Topiramate—migraine	0.000293	0.00165	CcSEcCtD
Crizotinib—MAP3K2—central nervous system—migraine	0.000293	0.00174	CbGeAlD
Crizotinib—EPHA4—cerebellum—migraine	0.000292	0.00174	CbGeAlD
Crizotinib—AURKA—brain—migraine	0.000291	0.00173	CbGeAlD
Crizotinib—Dyspepsia—Timolol—migraine	0.000291	0.00163	CcSEcCtD
Crizotinib—TESK1—brain—migraine	0.000288	0.00172	CbGeAlD
Crizotinib—Decreased appetite—Timolol—migraine	0.000287	0.00161	CcSEcCtD
Crizotinib—TBK1—central nervous system—migraine	0.000287	0.00171	CbGeAlD
Crizotinib—PTK2—central nervous system—migraine	0.000287	0.00171	CbGeAlD
Crizotinib—RPS6KB1—nervous system—migraine	0.000286	0.0017	CbGeAlD
Crizotinib—MAP3K2—cerebellum—migraine	0.000286	0.0017	CbGeAlD
Crizotinib—Gastrointestinal disorder—Timolol—migraine	0.000285	0.0016	CcSEcCtD
Crizotinib—TYK2—central nervous system—migraine	0.000285	0.00169	CbGeAlD
Crizotinib—FGR—nervous system—migraine	0.000285	0.00169	CbGeAlD
Crizotinib—Fatigue—Timolol—migraine	0.000285	0.0016	CcSEcCtD
Crizotinib—Syncope—Topiramate—migraine	0.000284	0.0016	CcSEcCtD
Crizotinib—JAK2—head—migraine	0.000284	0.00169	CbGeAlD
Crizotinib—Leukopenia—Topiramate—migraine	0.000284	0.00159	CcSEcCtD
Crizotinib—AXL—nervous system—migraine	0.000283	0.00169	CbGeAlD
Crizotinib—MERTK—brain—migraine	0.00028	0.00167	CbGeAlD
Crizotinib—EPHA2—head—migraine	0.00028	0.00167	CbGeAlD
Crizotinib—PTK2—cerebellum—migraine	0.00028	0.00167	CbGeAlD
Crizotinib—TBK1—cerebellum—migraine	0.00028	0.00167	CbGeAlD
Crizotinib—Loss of consciousness—Topiramate—migraine	0.000278	0.00157	CcSEcCtD
Crizotinib—TYK2—cerebellum—migraine	0.000278	0.00166	CbGeAlD
Crizotinib—Paraesthesia—Gabapentin—migraine	0.000276	0.00155	CcSEcCtD
Crizotinib—RPS6KB1—central nervous system—migraine	0.000276	0.00164	CbGeAlD
Crizotinib—IRAK1—cerebellum—migraine	0.000275	0.00163	CbGeAlD
Crizotinib—LIMK2—brain—migraine	0.000274	0.00163	CbGeAlD
Crizotinib—Dyspnoea—Gabapentin—migraine	0.000274	0.00154	CcSEcCtD
Crizotinib—FGR—central nervous system—migraine	0.000274	0.00163	CbGeAlD
Crizotinib—MAP4K5—head—migraine	0.000273	0.00163	CbGeAlD
Crizotinib—TEK—head—migraine	0.000273	0.00163	CbGeAlD
Crizotinib—MAP3K3—head—migraine	0.000273	0.00163	CbGeAlD
Crizotinib—NUAK2—brain—migraine	0.000273	0.00163	CbGeAlD
Crizotinib—AXL—central nervous system—migraine	0.000273	0.00162	CbGeAlD
Crizotinib—MAP3K12—brain—migraine	0.000271	0.00161	CbGeAlD
Crizotinib—ACVR1—brain—migraine	0.000271	0.00161	CbGeAlD
Crizotinib—Dyspepsia—Gabapentin—migraine	0.000271	0.00152	CcSEcCtD
Crizotinib—RPS6KB1—cerebellum—migraine	0.000269	0.0016	CbGeAlD
Crizotinib—JAK2—nervous system—migraine	0.000269	0.0016	CbGeAlD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000268	0.00151	CcSEcCtD
Crizotinib—Decreased appetite—Gabapentin—migraine	0.000267	0.0015	CcSEcCtD
Crizotinib—AXL—cerebellum—migraine	0.000267	0.00159	CbGeAlD
Crizotinib—Asthenia—Valproic Acid—migraine	0.000266	0.0015	CcSEcCtD
Crizotinib—STK35—brain—migraine	0.000266	0.00158	CbGeAlD
Crizotinib—EPHA2—nervous system—migraine	0.000266	0.00158	CbGeAlD
Crizotinib—Gastrointestinal disorder—Gabapentin—migraine	0.000265	0.00149	CcSEcCtD
Crizotinib—Fatigue—Gabapentin—migraine	0.000265	0.00149	CcSEcCtD
Crizotinib—Constipation—Gabapentin—migraine	0.000263	0.00148	CcSEcCtD
Crizotinib—EPHB6—head—migraine	0.000261	0.00156	CbGeAlD
Crizotinib—Body temperature increased—Timolol—migraine	0.000261	0.00147	CcSEcCtD
Crizotinib—MAP4K5—nervous system—migraine	0.000259	0.00154	CbGeAlD
Crizotinib—TEK—nervous system—migraine	0.000259	0.00154	CbGeAlD
Crizotinib—MAP3K3—nervous system—migraine	0.000259	0.00154	CbGeAlD
Crizotinib—ABL2—brain—migraine	0.000259	0.00154	CbGeAlD
Crizotinib—JAK2—central nervous system—migraine	0.000259	0.00154	CbGeAlD
Crizotinib—Oedema—Topiramate—migraine	0.000259	0.00145	CcSEcCtD
Crizotinib—Infection—Topiramate—migraine	0.000257	0.00144	CcSEcCtD
Crizotinib—SLK—cerebellum—migraine	0.000257	0.00153	CbGeAlD
Crizotinib—EPHA2—central nervous system—migraine	0.000256	0.00152	CbGeAlD
Crizotinib—BMP2K—brain—migraine	0.000256	0.00152	CbGeAlD
Crizotinib—EPHB4—cerebellum—migraine	0.000255	0.00152	CbGeAlD
Crizotinib—ABL1—cardiovascular system—migraine	0.000255	0.00152	CbGeAlD
Crizotinib—Shock—Topiramate—migraine	0.000254	0.00143	CcSEcCtD
Crizotinib—Diarrhoea—Valproic Acid—migraine	0.000254	0.00143	CcSEcCtD
Crizotinib—Nervous system disorder—Topiramate—migraine	0.000254	0.00143	CcSEcCtD
Crizotinib—JAK2—cerebellum—migraine	0.000253	0.00151	CbGeAlD
Crizotinib—YES1—head—migraine	0.000253	0.0015	CbGeAlD
Crizotinib—Skin disorder—Topiramate—migraine	0.000251	0.00141	CcSEcCtD
Crizotinib—STK10—head—migraine	0.00025	0.00149	CbGeAlD
Crizotinib—MAP4K5—central nervous system—migraine	0.00025	0.00149	CbGeAlD
Crizotinib—MAP3K3—central nervous system—migraine	0.00025	0.00149	CbGeAlD
Crizotinib—TEK—central nervous system—migraine	0.00025	0.00149	CbGeAlD
Crizotinib—TAOK3—head—migraine	0.000249	0.00148	CbGeAlD
Crizotinib—EPHB6—nervous system—migraine	0.000248	0.00147	CbGeAlD
Crizotinib—PTK2B—brain—migraine	0.000247	0.00147	CbGeAlD
Crizotinib—Dizziness—Valproic Acid—migraine	0.000245	0.00138	CcSEcCtD
Crizotinib—RIPK2—brain—migraine	0.000245	0.00146	CbGeAlD
Crizotinib—MAP4K5—cerebellum—migraine	0.000244	0.00145	CbGeAlD
Crizotinib—TEK—cerebellum—migraine	0.000244	0.00145	CbGeAlD
Crizotinib—MAP3K3—cerebellum—migraine	0.000244	0.00145	CbGeAlD
Crizotinib—Body temperature increased—Gabapentin—migraine	0.000243	0.00137	CcSEcCtD
Crizotinib—SRC—head—migraine	0.000243	0.00145	CbGeAlD
Crizotinib—YES1—nervous system—migraine	0.000239	0.00143	CbGeAlD
Crizotinib—EPHB6—central nervous system—migraine	0.000239	0.00142	CbGeAlD
Crizotinib—STK10—nervous system—migraine	0.000237	0.00141	CbGeAlD
Crizotinib—EPHA4—brain—migraine	0.000237	0.00141	CbGeAlD
Crizotinib—Asthenia—Timolol—migraine	0.000237	0.00133	CcSEcCtD
Crizotinib—TAOK3—nervous system—migraine	0.000236	0.00141	CbGeAlD
Crizotinib—Vomiting—Valproic Acid—migraine	0.000236	0.00133	CcSEcCtD
Crizotinib—Rash—Valproic Acid—migraine	0.000234	0.00131	CcSEcCtD
Crizotinib—Dermatitis—Valproic Acid—migraine	0.000234	0.00131	CcSEcCtD
Crizotinib—EPHB6—cerebellum—migraine	0.000233	0.00139	CbGeAlD
Crizotinib—MAP3K2—brain—migraine	0.000232	0.00138	CbGeAlD
Crizotinib—Paraesthesia—Topiramate—migraine	0.000232	0.00131	CcSEcCtD
Crizotinib—Dyspnoea—Topiramate—migraine	0.000231	0.0013	CcSEcCtD
Crizotinib—YES1—central nervous system—migraine	0.000231	0.00137	CbGeAlD
Crizotinib—SRC—nervous system—migraine	0.00023	0.00137	CbGeAlD
Crizotinib—STK10—central nervous system—migraine	0.000228	0.00136	CbGeAlD
Crizotinib—Dyspepsia—Topiramate—migraine	0.000228	0.00128	CcSEcCtD
Crizotinib—TAOK3—central nervous system—migraine	0.000228	0.00135	CbGeAlD
Crizotinib—TBK1—brain—migraine	0.000228	0.00135	CbGeAlD
Crizotinib—PTK2—brain—migraine	0.000228	0.00135	CbGeAlD
Crizotinib—TYK2—brain—migraine	0.000226	0.00135	CbGeAlD
Crizotinib—Diarrhoea—Timolol—migraine	0.000226	0.00127	CcSEcCtD
Crizotinib—YES1—cerebellum—migraine	0.000225	0.00134	CbGeAlD
Crizotinib—Decreased appetite—Topiramate—migraine	0.000225	0.00126	CcSEcCtD
Crizotinib—STK10—cerebellum—migraine	0.000223	0.00133	CbGeAlD
Crizotinib—Gastrointestinal disorder—Topiramate—migraine	0.000223	0.00125	CcSEcCtD
Crizotinib—IRAK1—brain—migraine	0.000223	0.00133	CbGeAlD
Crizotinib—Fatigue—Topiramate—migraine	0.000223	0.00125	CcSEcCtD
Crizotinib—TAOK3—cerebellum—migraine	0.000222	0.00132	CbGeAlD
Crizotinib—SRC—central nervous system—migraine	0.000222	0.00132	CbGeAlD
Crizotinib—Constipation—Topiramate—migraine	0.000221	0.00124	CcSEcCtD
Crizotinib—Asthenia—Gabapentin—migraine	0.000221	0.00124	CcSEcCtD
Crizotinib—Nausea—Valproic Acid—migraine	0.00022	0.00124	CcSEcCtD
Crizotinib—RPS6KB1—brain—migraine	0.000219	0.0013	CbGeAlD
Crizotinib—Dizziness—Timolol—migraine	0.000218	0.00123	CcSEcCtD
Crizotinib—CSF1R—head—migraine	0.000218	0.0013	CbGeAlD
Crizotinib—FGR—brain—migraine	0.000218	0.00129	CbGeAlD
Crizotinib—SRC—cerebellum—migraine	0.000217	0.00129	CbGeAlD
Crizotinib—AXL—brain—migraine	0.000217	0.00129	CbGeAlD
Crizotinib—Diarrhoea—Gabapentin—migraine	0.00021	0.00118	CcSEcCtD
Crizotinib—Vomiting—Timolol—migraine	0.00021	0.00118	CcSEcCtD
Crizotinib—SLK—brain—migraine	0.000209	0.00124	CbGeAlD
Crizotinib—Rash—Timolol—migraine	0.000208	0.00117	CcSEcCtD
Crizotinib—Dermatitis—Timolol—migraine	0.000208	0.00117	CcSEcCtD
Crizotinib—EPHB4—brain—migraine	0.000207	0.00123	CbGeAlD
Crizotinib—CSF1R—nervous system—migraine	0.000207	0.00123	CbGeAlD
Crizotinib—JAK2—brain—migraine	0.000206	0.00122	CbGeAlD
Crizotinib—Body temperature increased—Topiramate—migraine	0.000204	0.00115	CcSEcCtD
Crizotinib—Dizziness—Gabapentin—migraine	0.000203	0.00114	CcSEcCtD
Crizotinib—EPHA2—brain—migraine	0.000203	0.00121	CbGeAlD
Crizotinib—CSF1R—central nervous system—migraine	0.000199	0.00119	CbGeAlD
Crizotinib—TEK—brain—migraine	0.000198	0.00118	CbGeAlD
Crizotinib—MAP4K5—brain—migraine	0.000198	0.00118	CbGeAlD
Crizotinib—MAP3K3—brain—migraine	0.000198	0.00118	CbGeAlD
Crizotinib—Nausea—Timolol—migraine	0.000196	0.0011	CcSEcCtD
Crizotinib—Vomiting—Gabapentin—migraine	0.000195	0.0011	CcSEcCtD
Crizotinib—CSF1R—cerebellum—migraine	0.000195	0.00116	CbGeAlD
Crizotinib—Rash—Gabapentin—migraine	0.000194	0.00109	CcSEcCtD
Crizotinib—Dermatitis—Gabapentin—migraine	0.000194	0.00109	CcSEcCtD
Crizotinib—EPHB6—brain—migraine	0.000189	0.00113	CbGeAlD
Crizotinib—Asthenia—Topiramate—migraine	0.000186	0.00104	CcSEcCtD
Crizotinib—YES1—brain—migraine	0.000183	0.00109	CbGeAlD
Crizotinib—Nausea—Gabapentin—migraine	0.000183	0.00103	CcSEcCtD
Crizotinib—STK10—brain—migraine	0.000181	0.00108	CbGeAlD
Crizotinib—TAOK3—brain—migraine	0.000181	0.00108	CbGeAlD
Crizotinib—ABCB1—blood vessel—migraine	0.000177	0.00106	CbGeAlD
Crizotinib—Diarrhoea—Topiramate—migraine	0.000177	0.000995	CcSEcCtD
Crizotinib—SRC—brain—migraine	0.000176	0.00105	CbGeAlD
Crizotinib—ABL1—head—migraine	0.000172	0.00103	CbGeAlD
Crizotinib—Dizziness—Topiramate—migraine	0.000171	0.000961	CcSEcCtD
Crizotinib—Vomiting—Topiramate—migraine	0.000164	0.000924	CcSEcCtD
Crizotinib—ABL1—nervous system—migraine	0.000163	0.000973	CbGeAlD
Crizotinib—Rash—Topiramate—migraine	0.000163	0.000917	CcSEcCtD
Crizotinib—Dermatitis—Topiramate—migraine	0.000163	0.000916	CcSEcCtD
Crizotinib—CSF1R—brain—migraine	0.000158	0.000941	CbGeAlD
Crizotinib—ABL1—central nervous system—migraine	0.000157	0.000937	CbGeAlD
Crizotinib—ABL1—cerebellum—migraine	0.000154	0.000916	CbGeAlD
Crizotinib—Nausea—Topiramate—migraine	0.000154	0.000863	CcSEcCtD
Crizotinib—ABL1—brain—migraine	0.000125	0.000744	CbGeAlD
Crizotinib—ABCB1—trigeminal ganglion—migraine	0.00011	0.000653	CbGeAlD
Crizotinib—ABCB1—cardiovascular system—migraine	7.92e-05	0.000471	CbGeAlD
Crizotinib—CYP3A4—nervous system—migraine	7.18e-05	0.000427	CbGeAlD
Crizotinib—CYP3A4—central nervous system—migraine	6.91e-05	0.000412	CbGeAlD
Crizotinib—ABCB1—head—migraine	5.36e-05	0.000319	CbGeAlD
Crizotinib—ABCB1—nervous system—migraine	5.08e-05	0.000303	CbGeAlD
Crizotinib—ABCB1—central nervous system—migraine	4.89e-05	0.000291	CbGeAlD
Crizotinib—ABCB1—cerebellum—migraine	4.78e-05	0.000285	CbGeAlD
Crizotinib—ABCB1—brain—migraine	3.89e-05	0.000231	CbGeAlD
Crizotinib—YES1—Innate Immune System—FOS—migraine	2.51e-05	0.000157	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—HTR2C—migraine	2.51e-05	0.000157	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—PGR—migraine	2.51e-05	0.000157	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—NPS—migraine	2.51e-05	0.000157	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TAC1—migraine	2.51e-05	0.000157	CbGpPWpGaD
Crizotinib—EPHA2—Developmental Biology—TNF—migraine	2.5e-05	0.000157	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HTR2C—migraine	2.49e-05	0.000156	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HTR2C—migraine	2.46e-05	0.000154	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HTR1B—migraine	2.45e-05	0.000153	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HTR1B—migraine	2.45e-05	0.000153	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—HTR7—migraine	2.45e-05	0.000153	CbGpPWpGaD
Crizotinib—LCK—Disease—LRP1—migraine	2.45e-05	0.000153	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—EDNRA—migraine	2.44e-05	0.000153	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HTR1A—migraine	2.43e-05	0.000152	CbGpPWpGaD
Crizotinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—migraine	2.43e-05	0.000152	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—EDNRA—migraine	2.43e-05	0.000152	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—PGR—migraine	2.4e-05	0.00015	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—NPS—migraine	2.4e-05	0.00015	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TAC1—migraine	2.4e-05	0.00015	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—EDNRA—migraine	2.39e-05	0.00015	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR1D—migraine	2.39e-05	0.00015	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—FOS—migraine	2.38e-05	0.000149	CbGpPWpGaD
Crizotinib—TYK2—Disease—CALCA—migraine	2.38e-05	0.000149	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR2B—migraine	2.37e-05	0.000149	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—HTR2A—migraine	2.37e-05	0.000149	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—NOTCH3—migraine	2.36e-05	0.000148	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HTR1A—migraine	2.36e-05	0.000148	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HTR1A—migraine	2.36e-05	0.000148	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HTR2C—migraine	2.35e-05	0.000147	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—CALCA—migraine	2.35e-05	0.000147	CbGpPWpGaD
Crizotinib—TBK1—Immune System—FOS—migraine	2.35e-05	0.000147	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—CALCA—migraine	2.33e-05	0.000146	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—ESR1—migraine	2.33e-05	0.000146	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—NOTCH3—migraine	2.33e-05	0.000146	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—NPS—migraine	2.33e-05	0.000145	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TAC1—migraine	2.33e-05	0.000145	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—PGR—migraine	2.33e-05	0.000145	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—TAC1—migraine	2.32e-05	0.000145	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—NPS—migraine	2.32e-05	0.000145	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—HTR2A—migraine	2.32e-05	0.000145	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—FOS—migraine	2.32e-05	0.000145	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CALCA—migraine	2.3e-05	0.000144	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—EDNRA—migraine	2.29e-05	0.000143	CbGpPWpGaD
Crizotinib—CDK7—Disease—MTHFR—migraine	2.29e-05	0.000143	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HTR2C—migraine	2.28e-05	0.000143	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HTR2C—migraine	2.28e-05	0.000143	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—FOS—migraine	2.25e-05	0.000141	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—NOTCH3—migraine	2.23e-05	0.000139	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR2B—migraine	2.22e-05	0.000139	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—EDNRA—migraine	2.22e-05	0.000139	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—EDNRA—migraine	2.22e-05	0.000139	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CALCA—migraine	2.2e-05	0.000138	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—HTR7—migraine	2.2e-05	0.000138	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—ESR1—migraine	2.19e-05	0.000137	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HTR7—migraine	2.18e-05	0.000137	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—NOTCH4—migraine	2.18e-05	0.000136	CbGpPWpGaD
Crizotinib—SRC—Disease—LRP1—migraine	2.17e-05	0.000136	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	2.16e-05	0.000135	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—NOTCH3—migraine	2.16e-05	0.000135	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HTR7—migraine	2.15e-05	0.000135	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NOTCH4—migraine	2.15e-05	0.000135	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CALCA—migraine	2.14e-05	0.000134	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—CALCA—migraine	2.13e-05	0.000134	CbGpPWpGaD
Crizotinib—ABCB1—Allograft Rejection—TNF—migraine	2.12e-05	0.000133	CbGpPWpGaD
Crizotinib—JAK3—Immune System—FOS—migraine	2.12e-05	0.000133	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TGFBR2—migraine	2.11e-05	0.000132	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—ESR1—migraine	2.11e-05	0.000132	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HTR1B—migraine	2.1e-05	0.000132	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR1D—migraine	2.09e-05	0.000131	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—LRP1—migraine	2.09e-05	0.000131	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HTR1B—migraine	2.08e-05	0.00013	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—ESR1—migraine	2.06e-05	0.000129	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HTR7—migraine	2.06e-05	0.000129	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NOTCH4—migraine	2.04e-05	0.000128	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HTR1A—migraine	2.03e-05	0.000127	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HTR1A—migraine	2e-05	0.000125	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HTR7—migraine	2e-05	0.000125	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HTR7—migraine	2e-05	0.000125	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—NPS—migraine	2e-05	0.000125	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—PGR—migraine	2e-05	0.000125	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TAC1—migraine	2e-05	0.000125	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NOTCH4—migraine	1.98e-05	0.000124	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HTR1B—migraine	1.97e-05	0.000123	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TAC1—migraine	1.97e-05	0.000123	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NPS—migraine	1.97e-05	0.000123	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—PGR—migraine	1.97e-05	0.000123	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—LRP1—migraine	1.96e-05	0.000122	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HTR2C—migraine	1.96e-05	0.000122	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR2B—migraine	1.95e-05	0.000122	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HTR2C—migraine	1.93e-05	0.000121	CbGpPWpGaD
Crizotinib—TYK2—Disease—TGFBR2—migraine	1.91e-05	0.00012	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HTR1B—migraine	1.91e-05	0.00012	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—EDNRA—migraine	1.9e-05	0.000119	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HTR1A—migraine	1.89e-05	0.000119	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—FOS—migraine	1.89e-05	0.000118	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TGFBR2—migraine	1.88e-05	0.000118	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—EDNRA—migraine	1.88e-05	0.000117	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—FOS—migraine	1.87e-05	0.000117	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NPS—migraine	1.87e-05	0.000117	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—PGR—migraine	1.87e-05	0.000117	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TAC1—migraine	1.87e-05	0.000117	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—FOS—migraine	1.87e-05	0.000117	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—FOS—migraine	1.87e-05	0.000117	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—NOTCH3—migraine	1.85e-05	0.000116	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR1D—migraine	1.85e-05	0.000116	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TGFBR2—migraine	1.85e-05	0.000116	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—HTR2A—migraine	1.84e-05	0.000115	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HTR1A—migraine	1.84e-05	0.000115	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CALCA—migraine	1.83e-05	0.000115	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HTR2C—migraine	1.83e-05	0.000115	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NOTCH3—migraine	1.83e-05	0.000114	CbGpPWpGaD
Crizotinib—BLK—Immune System—FOS—migraine	1.82e-05	0.000114	CbGpPWpGaD
Crizotinib—FGR—Immune System—FOS—migraine	1.81e-05	0.000114	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CACNA1A—migraine	1.81e-05	0.000113	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—PGR—migraine	1.81e-05	0.000113	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TAC1—migraine	1.81e-05	0.000113	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NPS—migraine	1.81e-05	0.000113	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CALCA—migraine	1.81e-05	0.000113	CbGpPWpGaD
Crizotinib—JAK2—Disease—CALCA—migraine	1.8e-05	0.000113	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—EDNRA—migraine	1.78e-05	0.000111	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HTR2C—migraine	1.78e-05	0.000111	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TGFBR2—migraine	1.77e-05	0.000111	CbGpPWpGaD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.77e-05	0.000111	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—FOS—migraine	1.75e-05	0.00011	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NOTCH3—migraine	1.73e-05	0.000109	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—EDNRA—migraine	1.73e-05	0.000108	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR2B—migraine	1.72e-05	0.000108	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TGFBR2—migraine	1.72e-05	0.000108	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—HTR2A—migraine	1.72e-05	0.000107	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—LRP1—migraine	1.71e-05	0.000107	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CALCA—migraine	1.71e-05	0.000107	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HTR7—migraine	1.71e-05	0.000107	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HTR7—migraine	1.69e-05	0.000106	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NOTCH3—migraine	1.68e-05	0.000105	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CALCA—migraine	1.66e-05	0.000104	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NOTCH4—migraine	1.6e-05	0.0001	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HTR7—migraine	1.6e-05	0.0001	CbGpPWpGaD
Crizotinib—LCK—Disease—CALCA—migraine	1.58e-05	9.87e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HTR7—migraine	1.56e-05	9.74e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—MTHFR—migraine	1.55e-05	9.72e-05	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—TNF—migraine	1.55e-05	9.71e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR1B—migraine	1.55e-05	9.68e-05	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—HTR2A—migraine	1.54e-05	9.63e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—FOS—migraine	1.54e-05	9.61e-05	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—TNF—migraine	1.53e-05	9.58e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HTR2A—migraine	1.53e-05	9.57e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—ESR1—migraine	1.52e-05	9.53e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—LRP1—migraine	1.52e-05	9.49e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HTR2A—migraine	1.51e-05	9.43e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NOTCH4—migraine	1.5e-05	9.39e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR1A—migraine	1.49e-05	9.32e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—FOS—migraine	1.48e-05	9.29e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TGFBR2—migraine	1.48e-05	9.23e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PGR—migraine	1.47e-05	9.18e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NPS—migraine	1.47e-05	9.18e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TAC1—migraine	1.47e-05	9.18e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—FOS—migraine	1.46e-05	9.16e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TGFBR2—migraine	1.46e-05	9.11e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—TGFBR2—migraine	1.45e-05	9.07e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR1B—migraine	1.45e-05	9.06e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HTR2A—migraine	1.44e-05	9.03e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR2C—migraine	1.44e-05	9e-05	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—TNF—migraine	1.41e-05	8.82e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—EDNRA—migraine	1.4e-05	8.76e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HTR2A—migraine	1.4e-05	8.75e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HTR2A—migraine	1.4e-05	8.75e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—CALCA—migraine	1.4e-05	8.73e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR1A—migraine	1.39e-05	8.72e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—FOS—migraine	1.39e-05	8.69e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TGFBR2—migraine	1.38e-05	8.64e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TAC1—migraine	1.37e-05	8.59e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NPS—migraine	1.37e-05	8.59e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PGR—migraine	1.37e-05	8.59e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CACNA1A—migraine	1.37e-05	8.56e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NOTCH3—migraine	1.36e-05	8.53e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—FOS—migraine	1.36e-05	8.51e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—ESR1—migraine	1.36e-05	8.49e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—FOS—migraine	1.35e-05	8.44e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CALCA—migraine	1.35e-05	8.43e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR2C—migraine	1.35e-05	8.42e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TGFBR2—migraine	1.34e-05	8.38e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—ESR1—migraine	1.34e-05	8.37e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NOTCH4—migraine	1.31e-05	8.23e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—EDNRA—migraine	1.31e-05	8.2e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—ESR1—migraine	1.28e-05	8.01e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NOTCH3—migraine	1.28e-05	7.99e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—TGFBR2—migraine	1.27e-05	7.95e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR1B—migraine	1.27e-05	7.94e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CALCA—migraine	1.26e-05	7.89e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR7—migraine	1.26e-05	7.88e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—ESR1—migraine	1.24e-05	7.77e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR1A—migraine	1.22e-05	7.64e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NPS—migraine	1.2e-05	7.52e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TAC1—migraine	1.2e-05	7.52e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PGR—migraine	1.2e-05	7.52e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HTR2A—migraine	1.2e-05	7.51e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HTR2A—migraine	1.18e-05	7.41e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR7—migraine	1.18e-05	7.38e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR2C—migraine	1.18e-05	7.38e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—MTHFR—migraine	1.18e-05	7.37e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NOTCH4—migraine	1.16e-05	7.28e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—EDNRA—migraine	1.15e-05	7.18e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—TNF—migraine	1.14e-05	7.14e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—TNF—migraine	1.14e-05	7.11e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—TGFBR2—migraine	1.12e-05	7.04e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR1B—migraine	1.12e-05	7.03e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HTR2A—migraine	1.12e-05	7.02e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NOTCH3—migraine	1.12e-05	6.99e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CALCA—migraine	1.1e-05	6.91e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—FOS—migraine	1.09e-05	6.83e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HTR2A—migraine	1.09e-05	6.82e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—FOS—migraine	1.09e-05	6.8e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TGFBR2—migraine	1.09e-05	6.79e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR1A—migraine	1.08e-05	6.76e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—TNF—migraine	1.07e-05	6.68e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—ESR1—migraine	1.07e-05	6.67e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NPS—migraine	1.06e-05	6.66e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TAC1—migraine	1.06e-05	6.66e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PGR—migraine	1.06e-05	6.66e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—ESR1—migraine	1.05e-05	6.57e-05	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.05e-05	6.56e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR2C—migraine	1.04e-05	6.53e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR7—migraine	1.03e-05	6.46e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—MTHFR—migraine	1.03e-05	6.45e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—FOS—migraine	1.02e-05	6.39e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TGFBR2—migraine	1.02e-05	6.35e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—EDNRA—migraine	1.02e-05	6.35e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—ESR1—migraine	9.96e-06	6.23e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NOTCH3—migraine	9.9e-06	6.19e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CALCA—migraine	9.78e-06	6.12e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—ESR1—migraine	9.67e-06	6.05e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR7—migraine	9.14e-06	5.72e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—MTHFR—migraine	9.13e-06	5.71e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—FOS—migraine	8.95e-06	5.6e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TGFBR2—migraine	8.89e-06	5.57e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR2A—migraine	8.83e-06	5.52e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CACNA1A—migraine	8.43e-06	5.27e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TNF—migraine	8.28e-06	5.18e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR2A—migraine	8.26e-06	5.17e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—FOS—migraine	7.92e-06	4.96e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TGFBR2—migraine	7.87e-06	4.93e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—ESR1—migraine	7.83e-06	4.9e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—ESR1—migraine	7.33e-06	4.59e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR2A—migraine	7.23e-06	4.53e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ESR1—migraine	6.42e-06	4.02e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR2A—migraine	6.4e-06	4.01e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—MTHFR—migraine	6e-06	3.75e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ESR1—migraine	5.68e-06	3.56e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MTHFR—migraine	4.52e-06	2.83e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MTHFR—migraine	2.79e-06	1.74e-05	CbGpPWpGaD
